Early endocrine and molecular changes in metabolic syndrome models

Carlos Larqué1, Myrian Velasco, Victor Navarro-Tableros

  • 1Neuroscience Division, Department of Neural Development and Physiology, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico DF, Mexico.

IUBMB Life
|September 10, 2011
PubMed

Insights

Metabolic syndrome (MS) and type 2 diabetes (DM2) are global epidemics. Early changes in pancreatic beta cells, like increased GLUT2 expression, may explain insulin hypersecretion and offer insights into preventing these conditions.

Area of Science:

  • Metabolic disorders
  • Endocrinology
  • Molecular biology

Background:

  • Global epidemics of metabolic syndrome (MS) and type 2 diabetes mellitus (DM2) are linked to nutrient excess and low physical activity.
  • The precise molecular mechanisms driving MS development remain unclear.
  • Animal models are crucial for controlled studies of diet and genetic factors, but comparisons are challenging due to experimental variability.

Purpose of the Study:

  • To review existing animal models for MS and DM2 research.
  • To present original observations on early metabolic and pancreatic beta-cell changes in a novel rat model.
  • To elucidate early molecular events preceding pancreatic islet exhaustion.

Main Methods:

  • Review of various nonhuman animal models used in metabolic disease research.
  • Short-term metabolic and beta-cell analysis in adult Wistar rats.
  • Treatment of rats with 20% sucrose in drinking water to induce metabolic changes.
  • Assessment of GLUT2 expression in pancreatic beta cells.

Main Results:

  • Early increase in GLUT2 expression observed in pancreatic beta cells.
  • GLUT2 translocation to the cell membrane was noted.
  • These changes may contribute to observed insulin hypersecretion and hyperinsulinemia in the model rats.

Conclusions:

  • Understanding early molecular changes, such as GLUT2 upregulation, is critical for addressing MS and DM2.
  • Identifying these initial events could lead to strategies for preventing or reversing MS before type 2 diabetes develops.
  • This research contributes to the biomedical understanding of metabolic disease progression.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...